BioAtla, Inc. (BCAB) Balance Sheet

OTC Pink: BCABAssets, liabilities, debt and equity over 8 years.

BCAB balance sheet, 2025

December 31, 2025 · U.S. dollars

$13.8M assets = $50.0M liabilities + −$36.2M equity

What it owns$13.8MCash & ST investments: $7.1M (51.5%)Cash & ST investments$7.1M · 51%Other current: $895,000 (6.5%)PP&E: $5.7M (40.9%)PP&E $5.7MOther non-current: $163,000 (1.2%)=How it is financed$50.0MCurrent liabilities: $21.9M (43.8%)Current liabilities$21.9M · 44%Other LT liabilities: $28.1M (56.2%)Other LT liabilities$28.1M · 56%

Liabilities exceed assets: shareholders’ equity is negative (−$36.2M).

Both columns are drawn to the same scale: what BCAB owns equals what it owes plus shareholders’ equity. Hover a block for its value.

BCAB financial health

Current ratio0.37
Tight · current assets cover current liabilities 0.37×
Equity / assets−261.7%
Thin equity · of assets funded by shareholders
Cash / debt114.8%
Cash covers debt · cash & short-term investments vs total debt
Goodwill & intangibles0.0%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

BCAB balance sheet trends, 2018–2025

BioAtla, Inc. balance sheet trends
MetricTrendThenLatestChange
Total assets$16.6M2018$13.8M2025−2.6%/yr
Total liabilities$45.1M2018$50.0M2025+1.5%/yr
Shareholders’ equity−$28.5M2018−$36.2M2025—
Cash & short-term investments$10.9M2018$7.1M2025−5.9%/yr
Total debt$15.0M2018$6.2M2025−11.9%/yr
Net cash (debt)−$4.1M2018$918,0002025+$5.1M
Working capital$3.5M2018−$13.9M2025−$17.4M
Book value per share−$65.932018−$30.762025—
Current ratio1.3820180.372025−1.01
Debt / equity0.0020200.062024+0.06
Shares outstanding432K20181.2M2025+15.4%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

BCAB assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

BCAB liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

BCAB debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

BCAB balance sheet

BioAtla, Inc. annual balance sheet
20252024202320222021202020192018
Assets
Cash & short-term investments$7.1M$49.0M$111.5M$215.5M$245.0M$238.6M$3.7M$10.9M
Cash & equivalents$7.1M$49.0M$111.5M$215.5M$245.0M$238.6M$3.7M$10.9M
Receivables$0$0$0$0$0$0$0$0
Inventory$0$0$0$0$0$0$0$0
Other current assets$895,000$2.2M$4.9M$4.9M$2.3M$2.1M$803,000$1.8M
Total current assets$8.0M$51.2M$116.4M$220.4M$247.3M$240.7M$4.5M$12.7M
Property, plant & equipment (net)$5.7M$1.2M$3.1M$5.2M$7.0M$4.1M$4.7M$3.9M
Goodwill & intangible assets$0$0$0$0$0$0$0$0
Long-term investments$0$0$0$0$0$0$0$0
Other non-current assets$163,000$0$154,000$154,000$154,000$154,000$154,000$97,000
Total assets$13.8M$52.4M$119.7M$225.7M$254.4M$244.9M$9.3M$16.6M
Liabilities
Accounts payable$8.2M$1.9M$3.8M$4.2M$1.2M$2.5M$5.1M$2.0M
Short-term debt$1.4M$836,000$1.6M$1.5M$1.4M$682,000$9.7M—
Deferred revenue—————$19.8M$1.4M$169,000
Total current liabilities$21.9M$14.5M$28.3M$23.1M$19.8M$32.3M$26.7M$9.2M
Long-term debt$0$0$0$0$0$682,000$8.4M$15.0M
Lease obligations$6.2M$836,000$2.5M$4.0M$5.4M$0——
Other long-term liabilities$28.1M$23.6M$20.6M$22.3M$23.8M$2.0M$30.2M$20.9M
Total liabilities$50.0M$38.2M$49.0M$45.4M$43.6M$35.0M$65.3M$45.1M
Shareholders' equity
Common stock & paid-in capital$6,000$6,000$5,000$5,000$4,000$3,000$750,000$750,000
Retained earnings (deficit)−$545.6M−$486.0M−$416.3M−$292.8M−$186.3M−$90.9M−$148.4M−$118.6M
Accumulated other comprehensive income——$0—$0$0$0−$1.4M
Total shareholders' equity−$36.2M$14.3M$70.7M$180.3M$210.8M$210.0M−$56.0M−$28.5M
Key figures
Total debt$6.2M$836,000$2.5M$4.0M$5.4M$682,000$18.1M$15.0M
Net cash (debt)$918,000$48.2M$109.0M$211.5M$239.6M$237.9M−$14.4M−$4.1M
Working capital−$13.9M$36.7M$88.1M$197.3M$227.5M$208.4M−$22.2M$3.5M
Tangible book value−$36.2M$14.3M$70.7M$180.3M$210.8M$210.0M−$56.0M−$28.5M
Book value per share−$30.76$14.68$73.96$231.64$305.00$311.87−$83.12−$65.93
Shares outstanding1.2M971K956K779K691K673K673K432K
Current ratio0.373.524.119.5312.487.460.171.38
Quick ratio0.323.373.939.3212.367.400.141.18
Debt / equity—0.060.030.020.030.00——
Equity / assets−261.7%27.2%59.1%79.9%82.9%85.7%−599.4%−171.1%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 31, 2026); data from EODHD.

BCAB financial position

At the end of fiscal 2025 (December 31, 2025), BioAtla had total assets of $13.8 million (down 73.6% from a year earlier), total liabilities of $50.0 million and shareholders' equity of -$36.2 million. It held $7.1 million in cash and short-term investments against $6.2 million of debt, a net cash position of $0.9 million. Its current ratio was 0.37. In the latest quarter (ended June 30, 2026) total assets were $9.5 million and equity -$36.2 million.

Related: BCAB income statement, BCAB cash flow statement, BCAB key metrics. See the BCAB stock overview for the latest quote and news.

BCAB balance sheet FAQ

What are BioAtla's total assets?

BioAtla reported total assets of $13.8 million at the end of fiscal 2025 (December 31, 2025), compared with $52.4 million a year earlier.

How much debt does BioAtla have?

BioAtla had $6.2 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was —.

How much cash does BioAtla have?

BioAtla held $7.1 million in cash and short-term investments at the end of fiscal 2025; with $6.2 million of debt that is net cash of $0.9 million.

What is BioAtla's book value?

BioAtla's shareholders' equity (book value) was -$36.2 million at the end of fiscal 2025, or −$30.76 per share.

What is BioAtla's current ratio?

BioAtla had current assets of $8.0 million and current liabilities of $21.9 million, a current ratio of 0.37 (current liabilities exceed current assets).

Biotechnology: balance sheet